Ifenprodil
Template:Short description Template:Cs1 config Template:Short description <templatestyles src="Infobox drug/styles.css"/> Script error: No such module "Infobox".Template:Template otherScript error: No such module "TemplatePar".{{Infobox drug/maintenance categoriesTemplate:Yesno | drug_name = | INN = | _drugtype =
| _has_physiological_data= | _has_gene_therapy=
| vaccine_type= | mab_type= | _number_of_combo_chemicals=Script error: No such module "ParameterCount". | _vaccine_data= | _mab_data= | _mab_vaccine_data= | _mab_other_data=212712CC(C(C1=CC=C(C=C1)O)O)N2CCC(CC2)CC3=CC=CC=C31S/C21H27NO2/c1-16(21(24)19-7-9-20(23)10-8-19)22-13-11-18(12-14-22)15-17-5-3-2-4-6-17/h2-10,16,18,21,23-24H,11-15H2,1H3UYNVMODNBIQBMV-UHFFFAOYSA-NTemplate:StdinchiciteTemplate:Stdinchicite | _combo_data= | _physiological_data= | _clinical_data= Cerocral, Dilvax, VadilexCerebral vasodilators; NMDA receptor antagonistsC04 | _legal_data=
| _other_data=4-[2-(4-benzylpiperidin-1-yl)-1-hydroxypropyl]phenol
| _image_0_or_2 = Ifenprodil.svg | _image_LR =
| _datapage = Ifenprodil (data page) | _vaccine_target=_type_not_vaccine | _legal_all= | _ATC_prefix_supplemental=C04 | _has_EMA_link = | CAS_number=23210-56-2 | PubChem=3689 | ChemSpiderID=3561 | ChEBI=93829 | ChEMBL=305187 | DrugBank= | KEGG=D08064 | _hasInChI_or_Key=yes | UNII=R8OE3P6O5S | _hasJmol02 = |_hasMultipleCASnumbers = |_hasMultiplePubChemCIDs = |_hasMultipleChEBIs =
| _countSecondIDs=Script error: No such module "ParameterCount". | _countIndexlabels=Script error: No such module "ParameterCount". | _trackListSortletter= |QID = |QID2 = |Verifiedfields=verified |Watchedfields= |verifiedrevid=461742484}}
Ifenprodil, sold under the brand names Cerocral, Dilvax, and Vadilex, is a cerebral vasodilator that has been marketed in some countries, including in Japan, Hong Kong, and France.[1][2][3][4] It is currently under development for treatment of a variety of additional indications.[5]
Ifenprodil has multiple known pharmacological actions.[5] It is an inhibitor of the NMDA receptor,[6] specifically of NMDA receptors containing GluN1 and GluN2B subunits, the "ifenprodil binding site".[7] Additionally, ifenprodil inhibits GIRK channels[8] and interacts with α1-adrenergic,[5] serotonin,[9] and sigma receptors.[10][11][12][5]
Chemically, ifenprodil is a substituted phenethylamine and β-hydroxyamphetamine derivative.[2][3] It is used pharmaceutically as the tartrate salt.[1][2][3]
Research
Ifenprodil has been studied as a possible medication to prevent tinnitus after acoustic trauma.[13]
It is currently in phase II trials for cough and idiopathic pulmonary fibrosis, among other investigational uses.[5]
See also
- Traxoprodil (another β-hydroxyamphetamine NMDA receptor antagonist)
References
<templatestyles src="Reflist/styles.css" />
- ↑ a b Script error: No such module "citation/CS1".
- ↑ a b c Script error: No such module "citation/CS1".
- ↑ a b c Script error: No such module "citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ a b c d e Script error: No such module "citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
Script error: No such module "Check for unknown parameters".
Script error: No such module "Navbox". Script error: No such module "navboxes". Template:Adrenergic receptor modulators Template:Ionotropic glutamate receptor modulators Template:Ion channel modulators Template:Serotonin receptor modulators Template:Sigma receptor modulatorsScript error: No such module "navboxes".Script error: No such module "Check for unknown parameters". Script error: No such module "Navbox".